State of Alaska Department of Revenue’s PTC Therapeutics PTCT Stock Holding History

State of Alaska Department of Revenue’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.59M	Sell	31,782 -12,316	-28%	-$889K	0.03%	560
2026 Q1	$3M	Sell	44,098 -1,248	-3%	-$88.4K	0.03%	509
2025 Q4	$3.44M	Buy	45,346 +41,038	+953%	+$2.98M	0.04%	446
2025 Q3	$264K	Buy	+4,308	New	+$224K	﹤0.01%	1554

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State of Alaska Department of Revenue's PTCT Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its PTC Therapeutics (PTCT) stake by 28% in Q2 2026, selling an estimated $889K and leaving 31,782 shares worth $2.59M. The position accounts for 0.03% of the portfolio, ranked #560.

State of Alaska Department of Revenue first reported a position in PTCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.44M in Q4 2025. 225 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

State of Alaska Department of Revenue held 31,782 shares of PTC Therapeutics worth $2.59M as of Q2 2026.
State of Alaska Department of Revenue sold 12,316 PTC Therapeutics shares in Q2 2026, an estimated $889K.
PTC Therapeutics made up 0.03% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #560 holding.
State of Alaska Department of Revenue first reported a position in PTC Therapeutics in Q3 2025 and has held it in 4 quarters since.
State of Alaska Department of Revenue's PTC Therapeutics position peaked at $3.44M in Q4 2025.
225 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.